Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

695
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
695
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.

Gynecologic oncology·2026
Same author

Improved time-to-detection with the new formulation of BD BACTEC Plus Aerobic/F Culture Vials: a real-world evidence study.

Microbiology spectrum·2025
Same author

Enhancing blood culture volume with ultrathin-wall cannula devices.

Journal of clinical microbiology·2025
Same author

Sustained benefits of imetelstat on patient-reported fatigue in patients with lower-risk myelodysplastic syndromes ineligible for, or relapsed/refractory to, erythropoiesis-stimulating agents and high transfusion burden in the phase 3 IMerge study.

Leukemia & lymphoma·2024
Same author

Advances in the research of intestinal fungi in Crohn's disease.

World journal of gastroenterology·2024
Same author

The transfer of double cleavage embryos developed from two four-cell embryos may not represent an optimal treatment strategy in cycles with a greater number of four-cell embryos on Day 2.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2024

Related Experiment Video

Updated: Sep 21, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

A pragmatic approach for dynamically incorporating predicate device data in prospective diagnostic test studies.

Graeme L Hickey1, Valentin Parvu1, Yongqiang Zhang2

  • 1Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.

Journal of Biopharmaceutical Statistics
|June 1, 2022
PubMed
Summary

This study introduces a dynamic Bayesian method to incorporate historical data into new diagnostic test trials. This approach can reduce sample sizes and trial duration for developing accurate diagnostic tests.

Keywords:
AugmentationBayesiandiagnostic testssensitivity

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

545

Related Experiment Videos

Last Updated: Sep 21, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.2K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

545

Area of Science:

  • Medical Diagnostics
  • Biostatistics
  • Clinical Trial Design

Background:

  • Clinical studies are essential for validating new diagnostic tests.
  • Historical data from predicate devices can potentially optimize new test evaluation.
  • Reducing sample size and trial duration are key objectives in clinical study design.

Purpose of the Study:

  • To propose a dynamic Bayesian method for incorporating historical data into new diagnostic test studies.
  • To reduce sample size and trial duration by leveraging existing data.
  • To enable adaptive trial frameworks for early stopping based on success.

Main Methods:

  • Utilizing the Bayesian power prior method with a dynamically calculated power parameter.
  • Comparing historical and new data using a one-sided comparison.
  • Employing a scaled-Weibull discount function to adjust the effective sample size borrowed.
  • Integrating the method within an adaptive trial framework for early success termination.

Main Results:

  • The proposed dynamic method allows for effective down-weighting of historical data.
  • The approach is pragmatic and conservative, ensuring data integrity.
  • The method is demonstrated with an example for detecting Methicillin-resistant Staphylococcus aureus (MRSA).

Conclusions:

  • The dynamic Bayesian approach offers a viable strategy to optimize clinical trials for new diagnostic tests.
  • Incorporating historical data can lead to more efficient study designs.
  • This method supports the development of accurate diagnostic tools with reduced resource utilization.